2016 International Congress

Thursday, June 23, 2016

12:00pm-1:30pm

Sensorimotor impairments and the excitability of spinal cord in lead intoxicated rat during development and a potent restorative effect of curcumin

H. Benammi, O. El Hiba, H. Gamrani (Marrakesh, Morocco)

Neuropharmacology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Sensory gating and inhibition in dystonia

E. Antelmi, R. Erro, L. Rocchi, R. Liguori, M. Tinazzi, J. Rothwell, K. Bhatia (Bologna, Italy)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Sensory tricks in cervical dystonia

A. Gündüz, A.D. Elmali, G.S. Koçak, N. Uzun Adatepe, F. Karaali-Savrun, M. Kiziltan (Istanbul, Turkey)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Sensory tricks in primary blepharospasm and cervical dystonia

S. Pandey, G. Soni, N. Sarma (New Delhi, India)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Serum level of vitamin D3 in patients with neurodegenerative diseases compared to healthy adults and its correlation with the years spent from the initial diagnosis

A.N. Taravari (Skopje, Macedonia)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Significant improvement of adult-onset dystonia with cannabinoids-based oromucosal spray

M. Aguilar, S. Romero, L. Molina Porcel, P. Pastor (Terrassa, Spain)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Smell perception and judgement in PD patients: Results of a study designed, conducted, analysed and reported by PD patients

J. Stamford (London, United Kingdom)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Spectrum of acute movement disorders in a pediatric movement disorder clinic; Malaysian experience

T.A. Tajudin (Johor, Malaysia)

Pediatric movement disorder  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Speech and voice range profile in patients with Parkinson’s disease with deep brain stimulation: Preliminary data

G.L.A. Diaféria, A.E. Dias, M.J. Carvalho, R. Cury, E.R. Barbosa, E.T. Fonoff (São Paulo, Brazil)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Status of NPF-QII after six years: Updates to the dataset

F. Cubillos, E.C. Nelson, T. Simuni, C. Marras, M. Rafferty, T. Davis, P. Schmidt (Miami, FL, USA)

Parkinsons's Disease: Clinical Trials I